APA (7th ed.) Citation

T, R., N, B., C, M., G, D., X, W., M, L., . . . E, G. (2022). Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(2), 278. https://doi.org/10.1093/europace/euab182

Chicago Style (17th ed.) Citation

T, Rolland, et al. "Safety and Efficacy of Flecainide Associated with Beta-blockers in Arrhythmogenic Right Ventricular Cardiomyopathy." Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 24, no. 2 (2022): 278. https://doi.org/10.1093/europace/euab182.

MLA (9th ed.) Citation

T, Rolland, et al. "Safety and Efficacy of Flecainide Associated with Beta-blockers in Arrhythmogenic Right Ventricular Cardiomyopathy." Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol. 24, no. 2, 2022, p. 278, https://doi.org/10.1093/europace/euab182.